Skip to main content

Table 1 Myo-Inositol levels in 158JP oligodendrocytes, PMD fibroblasts and PMD lymphocytes

From: Targeted metabolomic analyses of cellular models of pelizaeus-merzbacher disease reveal plasmalogen and myo-inositol solute carrier dysfunction

Cells Myo-Inositol (-fold control)
158JP oligodendrocytes 8.7 ± 0.78
PMD Fibroblasts 6.8 ± 0.55
PMD Lymphocytes 1.9 ± 0.10
  1. N = 5 (repeated 3 times); all increases are significant (p < 0.01)